Forgot your password ?

 login: 

  Why you need to be registered

 password: 

 Register 

Current issueArchivesubscribeInstructions to Authors

search by
Google





subscribe on the news  

 

Pay Color Illustration
 


Medline

PubMed, a service of the National Library of Medicine

World Oncology Network

R.E.Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology



Vol. 26, No. 1, 2004 (March)

Content

EFFECT OF 2’-DEOXYISOGUANOSINE ON THE GROWTH OF HUMAN TUMOR AND NORMAL CELL LINES

 

Radoslawa Nowak1,*, Maria Sawardo-Rochowska2, Zygmunt Kazimierczuk3, Roman J. Nowak4

1Department of Molecular Biology, The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland
2Department of Immunology, The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland
3Institute of Chemistry, Agricultural University, and Laboratory of Experimental Pharmacology, Polish Academy of Sciences Medical Research Center, Warsaw, Poland
4Institute of Experimental Physics, Warsaw University, Warsaw, Poland

Abstract. Aim: To test the effect of 2’-deoxyisoguanosine as a specific substrate of HIV reverse transcriptase on the growth of cultured normal and cancer cells. Methods: The effect of 2’-deoxyisoguanosine on the growth of cells of two normal (telomerase-negative) and five cancer cell lines have been tested. Cell viability was assessed by MTT assay. Results: We have found that this nucleoside analogue has low potency and specificity in inhibiting tumor cell growth. IC50 ranged from 0.5 mM to 2 mM for tumor cells, and from 1 mM to more than 4 mM for normal cells. Conclusions: 2’-deoxyisoguanosine has low potency and specificity in inhibiting tumor cell growth, similar to other telomerase inhibitors.

Key Words: deoxyisoguanosine, telomere, telomerase, anticancer strategy.

Language:  English

[full text]




Copyright (c) MORION 1999-2008

Current issue | Archive | subscribe | Instructions to Authors | E-Mail to webmaster